Ecraid
Ecraid is a purpose-driven, people-centred European clinical research alliance dedicated to reducing the impact of infectious diseases through a long-term, sustainable, and innovative clinical research network. It aims to improve diagnostics, prevention, and treatment strategies, respond effectively to infectious disease threats, and accelerate the development of new interventions. Building on the foundations of EU-funded projects like COMBACTE and PREPARE, Ecraid operates a 'warm-base' network of over 1,250 clinical sites across 43 countries, offering rapid, high-quality, and cost-efficient clinical trials and research services. It collaborates with academia, industry, and government to enhance pandemic preparedness, combat antimicrobial resistance, and address emerging infectious diseases.
Industries
Nr. of Employees
large (251-1000)
Products
European randomized Phase IV trial for mpox antiviral (EPOXI)
Multinational, double-blind, placebo-controlled Phase IV trial evaluating an antiviral treatment for mpox with 2:1 randomisation to active drug versus placebo alongside standard care across several European countries.
Adaptive platform trial for Long COVID treatments (RECLAIM)
An adaptive platform trial evaluating the efficacy and safety of repurposed, widely available medicines for persistent post-COVID symptoms, designed for remote participation and multiple concurrent treatment arms.
European randomized Phase IV trial for mpox antiviral (EPOXI)
Multinational, double-blind, placebo-controlled Phase IV trial evaluating an antiviral treatment for mpox with 2:1 randomisation to active drug versus placebo alongside standard care across several European countries.
Adaptive platform trial for Long COVID treatments (RECLAIM)
An adaptive platform trial evaluating the efficacy and safety of repurposed, widely available medicines for persistent post-COVID symptoms, designed for remote participation and multiple concurrent treatment arms.
Services
On-demand access to a pre-engaged network of hospital, primary care and specialised sites for multicentre clinical studies and trials.
Selection, coordination and quality-controlled execution of laboratory analyses, sample logistics, and biobanking across routine and specialised microbiology laboratories.
Rapid identification and feasibility assessment of hospital and clinical sites using a detailed site capability database and local clinical liaisons.
GCP courses, adaptive trial design modules, webinars and investigator workshops to build local capacity and maintain network readiness.
Trigger-based assessment and mobilisation process to activate clinical research operations in response to emerging infectious disease threats, with defined response modes.
Provision of data collection systems, epidemiological study design, and statistical analysis support including methodological comparisons of statistical frameworks.
On-demand access to a pre-engaged network of hospital, primary care and specialised sites for multicentre clinical studies and trials.
Selection, coordination and quality-controlled execution of laboratory analyses, sample logistics, and biobanking across routine and specialised microbiology laboratories.
Rapid identification and feasibility assessment of hospital and clinical sites using a detailed site capability database and local clinical liaisons.
GCP courses, adaptive trial design modules, webinars and investigator workshops to build local capacity and maintain network readiness.
Trigger-based assessment and mobilisation process to activate clinical research operations in response to emerging infectious disease threats, with defined response modes.
Provision of data collection systems, epidemiological study design, and statistical analysis support including methodological comparisons of statistical frameworks.
Expertise Areas
- Pan-European clinical trial network management
- Adaptive platform trial design and operations
- Infectious disease clinical trials (Phase I–IV)
- Laboratory network coordination and clinical microbiology
Key Technologies
- Adaptive platform trial methodologies
- Electronic data capture (web-based EDC)
- Network management systems (NMS) for sites
- Biobanking infrastructure
News & Updates
Ecraid launch event
Official launch of Ecraid, highlighting its vision, studies, and collaborations with EU projects and the European Commission.
Outbreak response modes
Ecraid operates in four outbreak response modes to respond rapidly to infectious disease threats, from inter-epidemic studies to emergency outbreak trials.
Ecraid and EU collaborations
Partnerships with EU-funded projects like COMBACTE, PREPARE, and VACCELERATE to strengthen infectious disease research infrastructure.
Research and training initiatives
Various studies, white papers, webinars, and educational activities to advance clinical research methodologies and infectious disease knowledge.
The importance of pan-European infectious disease research networks
Ecraid emphasizes the need for a coordinated, pan-European approach to infectious disease research to improve outcomes and pandemic preparedness.
Adaptive platform trial design in infectious diseases
Ecraid promotes the use of adaptive trial designs to increase efficiency and flexibility in clinical research.
Ecraid launch event
Official launch of Ecraid, highlighting its vision, studies, and collaborations with EU projects and the European Commission.
Outbreak response modes
Ecraid operates in four outbreak response modes to respond rapidly to infectious disease threats, from inter-epidemic studies to emergency outbreak trials.
Ecraid and EU collaborations
Partnerships with EU-funded projects like COMBACTE, PREPARE, and VACCELERATE to strengthen infectious disease research infrastructure.
Research and training initiatives
Various studies, white papers, webinars, and educational activities to advance clinical research methodologies and infectious disease knowledge.
The importance of pan-European infectious disease research networks
Ecraid emphasizes the need for a coordinated, pan-European approach to infectious disease research to improve outcomes and pandemic preparedness.
Adaptive platform trial design in infectious diseases
Ecraid promotes the use of adaptive trial designs to increase efficiency and flexibility in clinical research.